Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,417
datasets available to search
ShareScore release 0.9.0
Dataset results
1,417 results for “triple negative breast cancer”
Looking At Triple Negative Breast Cancer Patient Experience Patterns in Medical Trials
ClinicalTrials.gov study NCT05769491. IPD Sharing: UNDECIDED. Countries: 0. Publications: 3.
Estradiol in Treating Patients With ER Beta Positive, Triple Negative Locally Advanced or Metastatic Breast Cancer
ClinicalTrials.gov study NCT03941730. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Data from: Location of triple-negative breast cancers: comparison with estrogen receptor-positive breast cancers on MR imaging
Open the record for dataset details and reuse information.
Spatially distinct cellular and molecular landscapes define prognosis in triple negative breast cancer
GEO Series GSE295934. synthetic construct; Homo sapiens. 1440 samples. Type: Other.
miRNA analysis of triple-negative breast cancers in association with clinical and molecular phenotypes
GEO Series GSE40267. Homo sapiens. 181 samples. Type: Non-coding RNA profiling by array.
Gene expression profiles of triple-negative breast cancer cells under the condition of 3D proliferation
GEO Series GSE36953. Homo sapiens. 6 samples. Type: Expression profiling by array.
Multi-omics data integration reveals correlated regulatory features of triple negative breast cancer
GEO Series GSE171958. Homo sapiens. 27 samples. Type: Methylation profiling by array; Expression profiling by high throughput sequencing.
In vivo CRISPR screens identify Mga as an immunotherapy target in triple-negative breast cancer
GEO Series GSE249759. Mus musculus. 12 samples. Type: Expression profiling by high throughput sequencing.
MUC1-C INDUCES PBRM1-MEDIATED CHROMATIN REMODELING IN DRIVING CHRONIC INFLAMMATION AND DNA DAMAGE RESISTANCE IN TRIPLE-NEGATIVE BREAST CANCER [BT549_shIRF1]
GEO Series GSE212168. Homo sapiens. 6 samples. Type: Expression profiling by high throughput sequencing.
Gene expression profiling of triple-negative breast cancer cells and liver cancer cells perturbed by BET inhibitor JQ1
GEO Series GSE294293. Homo sapiens. 12 samples. Type: Expression profiling by high throughput sequencing.
DNA methylation profiling of 154 triple negative breast cancers using the Illumina EPIC 850K platform
GEO Series GSE148906. Homo sapiens. 154 samples. Type: Methylation profiling by array.
TBCRC 039: A phase II study of preoperative ruxolitinib with or without paclitaxel for triple-negative inflammatory breast cancer
GEO Series GSE232764. Homo sapiens. 17 samples. Type: Expression profiling by high throughput sequencing.
Identification of Prognostic Genes for Recurrent Risk Prediction in Triple Negative Breast Cancer Patients in Taiwan
GEO Series GSE33095. Homo sapiens. 4 samples. Type: Third-party reanalysis; Expression profiling by array.
Gene expression microarray and CGH array of metabolically adaptable cells derived from SUM149 triple-negative Inflammatory Breast Cancer cell line
GEO Series GSE60017. Homo sapiens. 5 samples. Type: Expression profiling by array; Genome binding/occupancy profiling by genome tiling array.
Discovery, Validation and Mechanistic study of XPO1 inhibition in the Treatment of Triple Negative Breast Cancer
GEO Series GSE278241. Homo sapiens. 48 samples. Type: Expression profiling by high throughput sequencing.
SMAD2 binding regions in triple negative breast cancer cell line, Hs578T
GEO Series GSE117496. Homo sapiens. 6 samples. Type: Genome binding/occupancy profiling by high throughput sequencing.
BLU-222, a Potent CDK2 Inhibitor, Synergizes with CDK4/6 Inhibitors to Overcome Drug Resistance in HR–Positive and Triple-Negative Breast Cancer by Inducing p21 and p27
GEO Series GSE282705. Homo sapiens. 90 samples. Type: Expression profiling by high throughput sequencing.
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination (ChIPseq)
GEO Series GSE116879. Homo sapiens. 36 samples. Type: Genome binding/occupancy profiling by high throughput sequencing.
Novel long non‐coding RNA 005620 induces epirubicin resistance of triple-negative breast cancer via regulating ITGB1 expression
GEO Series GSE152003. Homo sapiens. 9 samples. Type: Non-coding RNA profiling by high throughput sequencing.
Exploring mechanism the transcription factor SIPA1 promote the progression of triple-negative breast cancer
GEO Series GSE221742. Homo sapiens. 9 samples. Type: Expression profiling by high throughput sequencing.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.